HemostOD SA

Producer of donor free universal platelets for transfusion

HemostOD is assembling a novel, cell-based production platform based on natural human biology that makes blood platelets for transfusion in hours, not the days taken by its competitors. In pre-clinical development, the technology manufactures blood platelets outside the body from genetically modified CD34+ adult stem cells, rapidly and scalably, as a substitute to platelets from blood donors, which are in perennial short supply.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
REGISTER

No milestones

No Jobs

No videos and documents

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (50'000) 2021

Website

EPFL Spin-Off

EPFL Spin-Off 2020

Website

Venture Leaders Biotech

Venture Leaders Biotech 2025

HemostOD SA

Producer of donor free universal platelets for transfusion

Website:
www.hemostod.com

Headquarter:
St Sulpice

Foundation Date:
July 2020

Technology:

  • Biotech

Sectors:

  • Biotech
  • Cancer
  • Drug development platforms
  • Research and development
  • Surgery
  • Wound management

Support received

  • Support venture leaders
  • Support venturekick